CD133 in brain tumor: the prognostic factor

por Li, Bin, McCrudden, Cian M., Yuen, Hiu Fung, Xi, Xinping, Lyu, Peng, Chan, Kwok Wah, Zhang, Shu Dong, Kwok, Hang Fai
Publicado 2016

TAZ Expression as a Prognostic Indicator in Colorectal Cancer

por Yuen, Hiu-Fung, McCrudden, Cian M., Huang, Yu-Han, Tham, Jill M., Zhang, Xiaoqian, Zeng, Qi, Zhang, Shu-Dong, Hong, WanJin
Publicado 2013

In vitro and clinical data analysis of Osteopontin as a prognostic indicator in colorectal cancer

por Wei, Ran, Wong, Janet Pik Ching, Lyu, Peng, Xi, Xinping, Tong, Olivia, Zhang, Shu‐Dong, Yuen, Hiu Fung, Shirasawa, Senji, Kwok, Hang Fai
Publicado 2018

Correction: TAZ Expression as a Prognostic Indicator in Colorectal Cancer

por Yuen, Hiu-Fung, McCrudden, Cian M., Huang, Yu-Han, Tham, Jill M., Zhang, Xiaoqian, Zeng, Qi, Zhang, Shu-Dong, Hong, WanJin
Publicado 2021

The prognostic significance of Cdc6 and Cdt1 in breast cancer

por Mahadevappa, Ravikiran, Neves, Henrique, Yuen, Shun Ming, Bai, Yuchen, McCrudden, Cian M., Yuen, Hiu Fung, Wen, Qing, Zhang, Shu Dong, Kwok, Hang Fai
Publicado 2017

DNA Replication Licensing Protein MCM10 Promotes Tumor Progression and Is a Novel Prognostic Biomarker and Potential Therapeutic Target in Breast Cancer

por Mahadevappa, Ravikiran, Neves, Henrique, Yuen, Shun Ming, Jameel, Muhammad, Bai, Yuchen, Yuen, Hiu-Fung, Zhang, Shu-Dong, Zhu, Youzhi, Lin, Yao, Kwok, Hang Fai
Publicado 2018

PRL-3 activates mTORC1 in Cancer Progression

por Ye, Zu, Al-aidaroos, Abdul Qader Omer, Park, Jung Eun, Yuen, Hiu Fung, Zhang, Shu Dong, Gupta, Abhishek, Lin, Youbin, Shen, Han-Ming, Zeng, Qi
Publicado 2015

Clinical and in vitro analysis of Osteopontin as a prognostic indicator and unveil its potential downstream targets in bladder cancer

por Wong, Janet P.C., Wei, Ran, Lyu, Peng, Tong, Olivia L.H., Zhang, Shu Dong, Wen, Qing, Yuen, Hiu Fung, El-Tanani, Mohamed, Kwok, Hang Fai
Publicado 2017

The prognostic significance of protein tyrosine phosphatase 4A2 in breast cancer

por Zhao, Duanzheng, Guo, Libin, Neves, Henrique, Yuen, Hiu-Fung, Zhang, Shu-Dong, McCrudden, Cian M, Wen, Qing, Zhang, Jin, Zeng, Qi, Kwok, Hang Fai, Lin, Yao
Publicado 2015

Impact of oncogenic driver mutations on feedback between the PI3K and MEK pathways in cancer cells

por Yuen, Hiu-Fung, Abramczyk, Olga, Montgomery, Grant, Chan, Ka-Kui, Huang, Yu-Han, Sasazuki, Takehiko, Shirasawa, Senji, Gopesh, Srivastava, Chan, Kwok-Wah, Fennell, Dean, Janne, Pasi, El-Tanani, Mohamed, Murray, James T.
Publicado 2012

Oncogenic roles of PRL-3 in FLT3-ITD induced acute myeloid leukaemia

por Park, Jung Eun, Yuen, Hiu Fung, Zhou, Jian Biao, Al-aidaroos, Abdul Qader O, Guo, Ke, Valk, Peter J, Zhang, Shu Dong, Chng, Wee Joo, Hong, Cheng William, Mills, Ken, Zeng, Qi
Publicado 2013

Ran GTPase promotes cancer progression via Met receptor-mediated downstream signaling

por Yuen, Hiu-Fung, Chan, Ka-Kui, Platt-Higgins, Angela, Dakir, El-Habib, Matchett, Kyle B., Haggag, Yusuf Ahmed, Jithesh, Puthen V., Habib, Tanwir, Faheem, Ahmed, Dean, Fennell A., Morgan, Richard, Rudland, Philip S., El-Tanani, Mohamed
Publicado 2016

Vasoactivity of Rucaparib, a PARP-1 Inhibitor, is a Complex Process that Involves Myosin Light Chain Kinase, P2 Receptors, and PARP Itself

por McCrudden, Cian M., O’Rourke, Martin G., Cherry, Kim E., Yuen, Hiu-Fung, O’Rourke, Declan, Babur, Muhammad, Telfer, Brian A., Thomas, Huw D., Keane, Patrick, Nambirajan, Thiagarajan, Hagan, Chris, O’Sullivan, Joe M., Shaw, Chris, Williams, Kaye J., Curtin, Nicola J., Hirst, David G., Robson, Tracy
Publicado 2015

Erythropoietin drives breast cancer progression by activation of its receptor EPOR

por Chan, Ka Kui, Matchett, Kyle B., Coulter, Jonathan A., Yuen, Hiu-Fung, McCrudden, Cian M., Zhang, Shu-Dong, Irwin, Gareth W., Davidson, Matthew A., Rülicke, Thomas, Schober, Sophie, Hengst, Ludger, Jaekel, Heidelinde, Platt-Higgins, Angela, Rudland, Philip S., Mills, Ken I., Maxwell, Perry, El-Tanani, Mohamed, Lappin, Terence R.
Publicado 2017